We recently compiled a list of the 10 Best Pharma Stocks To Buy Right Now. In this article, we are going to take a look at ...

Merck (MRK) will be in focus as company beats revenue forecasts despite in line earnings amid strong Keytruda sales in Q3 ...

Thank you, Shirley, and good morning, everyone. Welcome to Merck's third-quarter 2024 conference call. Speaking on today's call will be Rob Davis, chairman and chief executive officer; Caroline ...

2024 EPS Guidance: $7.72 to $7.77. Merck & Co Inc (NYSE:MRK) reported a 4% increase in revenues for the quarter, or 7% on a constant currency basis, driven by strong performance in key areas like ...

Looking at the universe of stocks we cover at Dividend Channel, in trading on Thursday, shares of Merck & Co Inc (Symbol: MRK) were yielding above the 3% mark based on its quarterly dividend ...

Below is Validea's guru fundamental report for MERCK & CO INC (MRK). Of the 22 guru strategies we follow, MRK rates highest using our Earnings Yield Investor model based on the published strategy ...

We came across a bullish thesis on Merck & Co., Inc. (MRK) on Disruptive analytics’s Substack by Magnus Ofstad. In this ...

Merck's Q3 revenue rises, led by Keytruda's strong 17% YoY growth. Gardasil demand challenges in China impact sales, with ...

The leading altcoin has shifted global financial markets and amassed a global market capitalization of $320.32 billion. ETH ...

2024 Revenue Guidance: $63.6 to $64.1 billion, representing 6% to 7% growth. 2024 EPS Guidance: $7.72 to $7.77. Merck & Co Inc (NYSE:MRK) reported a 4% increase in revenues for the quarter, or 7% on a ...